[1] | Taher AT, Weatherall DJ, Cappellini MD . Thalassaemia. Lancet, 2018,391(10116):155-167. | [2] | Xiangmin Xu. Guidelines for thalassemia prevention and control programme. People’s Military Medical Press, 2011. | [2] | 徐湘民 . 地中海贫血预防控制操作指南. 北京:人民军医出版社, 2011 | [3] | Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, editors . Guidelines for the management of transfusion dependent thalassaemia (TDT) [Internet]. 3rd edition.Nicosia (CY): Thalassaemia International Federation; 2014. | [4] | Taher A, Vichinsky E, Musallam K, Cappellini MD Viprakasit V, authors Weatherall D, editor , Guidelines for the management of non transfusion dependent thalassaemia (NTDT) [Internet]. Nicosia,Cyprus: Thalassaemia International Federation; 2013. | [5] | Origa R . β-Thalassemia. Genet Med, 2017,19(6):609-619. | [6] | Shang X, Xu X . Update in the genetics of thalassemia: What clinicians need to know. Best Pract Res Cl Ob, 2017,9:3-15. | [7] | Mettananda S, Higgs DR . Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin N, 2018,32(2):177-191. | [8] | Clark B, Shooter C, Smith F, Brawand D, Steedman L, Oakley M, Rushton P, Rooks H, Wang X, Drousiotou A, Kyrri A, Hadjigavriel M, Will A, Fisher C, Higgs DR, Phylipsen M, Harteveld C, Kleanthous M, Thein SL . Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis. Br J Haematol, 2018,180(1):160-164. | [9] | Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S, Amson R, Telerman A, Nielsen P, Kohne E, Balser C, Heimpel H . A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene. Blood, 2011,118(25):6660-6666. | [10] | Liu D, Yi S, Zhang X, Fang P, Zheng C, Lin L, Cai R, Ye Y, Zhou Y, Liang Y, Cheng F, Zhang X, Zhou W, Mohandas N, An X, Xu X . Human STEAP3 mutations with no phenotypic red cell changes. Blood, 2016,127(8):1067-1071. | [11] | Ragab SM, Badr EA, Ibrahim AS . Evaluation of glutathione-S-Transferase P1 polymorphism and its relation to bone mineral density in egyptian children and adolescents with Beta-thalassemia Major. Mediterr J Hematol Infect Dis, 2016,8(1):e2016004. | [12] | Mokhtar GM, Sherif EM, Habeeb NM, Abdelmaksoud AA, El-Ghoroury EA, Ibrahim AS, Hamed EM . Glutathione S-transferase gene polymorphism: relation to cardiac iron overload in egyptian patients with beta thalassemia major. Hematology, 2015,21(1):46-53. | [13] | Mettananda S, Gibbons RJ, Higgs DR . α-Globin as a molecular target in the treatment of β-thalassemia. Blood, 2015,125(24):3694-701. | [14] | Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Usala G, Busonero F, Maschio A, Albai G, Piras MG, Sestu N, Lai S, Dei M, Mulas A, Crisponi L, Naitza S, Asunis I, Deiana M, Nagaraja R, Perseu L, Satta S, Cipollina MD, Sollaino C, Moi P, Hirschhorn JN, Orkin SH, Abecasis GR, Schlessinger D, Cao A . Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA, 2008,105(5):1620-1625. | [15] | Liu D, Zhang X, Yu L, Cai R, Ma X, Zheng C, Zhou Y, Liu Q, Wei X, Lin L, Yan T, Huang J, Mohandas N, An X, Xu X . KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood, 2014,124(5):803-811. | [16] | Guo XQ . Progress on genes related to fetal hemoglobin quantitative trait. Hereditas(Beijing), 2010,32(4):295-300. | [16] | 郭晓强 . 胎儿血红蛋白数量性状相关基因的研究进展. 遗传, 2010,32(4):295-300. | [17] | Rujito L, Basalamah M, Siswandari W, Setyono J, Wulandari G, Mulatsih S, Sofro AS, Sadewa AH, Sutaryo S . Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: a study on β-thalassemia and hemoglobin E/β-thalassemia patients in indonesia. Hematol Oncol Stem Cell Ther, 2016,9(2):55-63. | [18] | Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, Chen DD, Schupp PG, Vinjamur DS, Garcia SP, Luc S, Kurita R, Nakamura Y, Fujiwara Y, Maeda T, Yuan GC, Zhang F, Orkin SH, Bauer DE . BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature, 2015,527(7577):192-197. | [19] | Martyn GE, Wienert B, Yang L, Shah M, Norton LJ, Burdach J, Kurita R, Nakamura Y, Pearson RCM, Funnell APW, Quinlan KGR, Crossley M . Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. Nat Genet, 2018,50(4):498-503. | [20] | Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, Fisher C, Suciu M, Martyn GE, Norton LJ, Zhu C, Kurita R, Nakamura Y, Xu J, Higgs DR, Crossley M, Bauer DE, Orkin SH, Kharchenko PV, Maeda T . Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science, 2016,351(6270):285-289. | [21] | Perkins A, Xu X, Higgs DR, Patrinos GP, Arnaud L, Bieker JJ, Philipsen S , KLF1 Consensus Workgroup. Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood, 2016,127(15):1856-1862. | [22] | Lai Y, Chen Y, Chen B, Zheng H, Yi S, Li G, Wei H, He S, Zheng C . Genetic variants at BCL11A and HBS1L-MYB loci influence Hb F levels in Chinese Zhuang β-Thalassemia intermedia patients. Hemoglobin, 2016,40(6):405-410. | [23] | Sankaran VG, Menne TF, ćepanović D, Vergilio JA, Ji P, Kim J, Thiru P, Orkin SH, Lander ES, Lodish HF . MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA, 2011,108(4):1519-1524. | [24] | Chen Z, Tang H, Qayyum R, Schick UM, Nalls MA, Handsaker R, Li J, Lu Y, Yanek LR, Keating B, Meng Y, van Rooij FJ, Okada Y, Kubo M, Rasmussen-Torvik L, Keller MF, Lange L, Evans M, Bottinger EP, Linderman MD, Ruderfer DM, Hakonarson H, Papanicolaou G, Zonderman AB, Gottesman O; BioBank Japan Project; CHARGE Consortium, Thomson C, Ziv E, Singleton AB, Loos RJ, Sleiman PM, Ganesh S, McCarroll S, Becker DM, Wilson JG, Lettre G, Reiner AP . Genome-wide association analysis of red blood cell traits in african americans: the COGENT Network. Hum Mol Genet, 2013,22(12):2529-2538. | [25] | Liu RR, Wang MY, Lai YR . Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China. J Hematol Oncol, 2010,3:29. | [26] | Mtatiro SN, Makani J, Mmbando B, Thein SL, Menzel S, Cox SE . Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in tanzania. Am J Hematol, 2015,90(1):E1-4. | [27] | Wienert B, Martyn GE, Funnell APW, Quinlan KGR, Crossley M . Wake-up sleepy gene: reactivating fetal globin for β-hemoglobinopathies. Trends Genet, 2018,34(12):927-940. | [28] | Martyn GE, Wienert B, Kurita R, Nakamura Y, Quinlan KGR, Crossley M . A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site. Blood, 2019,133(8):852-856. | [29] | Joly P, Lacan P, Garcia C, Meley R, Pondarré C, Francina A . A novel deletion/insertion caused by a replication error in the β-globin gene locus control region. Hemoglobin, 2011,35(4):316-322. | [30] | Kim YW, Kim A . Deletion of transcription factor binding motifs using the CRISPR/spCas9 system in the β-globin LCR. Bioscience Rep, 2017, 37(4): BSR20170976. | [31] | Ju JY, Zhao Q . Regulation of γ-globin gene expression and its clinical applications. Hereditas(Beijing), 2018,40(6):429-444. | [31] | 鞠君毅, 赵权 . γ-珠蛋白基因表达调控机制与临床应用. 遗传, 2018,40(6):429-444. | [32] | Ley TJ, Anagnou NP, Noguchi CT, Schechter AN, DeSimone J, Heller P, Nienhuis AW . DNA methylation and globin gene expression in patients treated with 5-azacytidine. Prog Clin Biol Res, 1983,134:457-474. | [33] | Chen D, Zuo Y, Zhang X, Ye Y, Bao X, Huang H, Tepakhan W, Wang L, Ju J, Chen G, Zheng M, Liu D, Huang S, Zong L, Li C, Chen Y, Zheng C, Shi L, Zhao Q, Wu Q, Fucharoen S, Zhao C, Xu X . A genetic variant ameliorates β-Thalassemia severity by epigenetic-mediated elevation of human fetal hemoglobin expression. Am J Hum Genet, 2017,101(1):130-138. | [34] | Mettananda S, Fisher CA, Sloane-Stanley JA, Taylor S, Oppermann U, Gibbons RJ, Higgs DR . Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia. Haematologica, 2017,102(3):e80-e84. | [35] | Dai Y, Chen T, Ijaz H, Cho EH, Steinberg MH . SIRT1 activates the expression of fetal hemoglobin genes. Am J Hematol, 2017,92(11):1177-1186. | [36] | Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G, Pissard S, Joly P, Thuret I, Origa R, Borg J, Forni GL, Piga A, Lai ME, Badens C, Moi P, Galanello R . A genetic score for the prediction of beta-thalassemia severity. Haematologica, 2015,100(4):452-457. | [37] | Wu Y, Zeng J, Roscoe BP, Liu P, Yao Q, Lazzarotto CR, Clement K, Cole MA, Luk K, Baricordi C, Shen AH, Ren C, Esrick EB, Manis JP, Dorfman DM, Williams DA, Biffi A, Brugnara C, Biasco L, Brendel C, Pinello L, Tsai SQ, Wolfe SA, Bauer DE . Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med, 2019,25(5):776-783. |
|